TSH Biopharm Corp. Ltd.(TW:8432)
NT$61.90+0.40 (+0.65%)
TW:8432
TSH Biopharm Corp. Ltd. financials statements
NT$61.90
At close:+0.40 (+0.65%)
TSH Biopharm Corp. Ltd. (8432) Income Statement
TSH Biopharm Corp. Ltd. Income Statement
Last quarter (Q2 2026), TSH Biopharm Corp. Ltd.'s total revenue was NT$330.69M, an increase of 22.80% from the same quarter last year. In Q2, TSH Biopharm Corp. Ltd.'s net income was NT$45.85M. See TSH Biopharm Corp. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.34B | NT$ 1.12B | NT$ 810.92M | NT$ 741.07M | NT$ 413.48M | |
| NT$ 657.13M | NT$ 582.76M | NT$ 399.90M | NT$ 389.87M | NT$ 247.36M | |
| NT$ 438.76M | NT$ 412.14M | NT$ 336.27M | NT$ 320.81M | NT$ 191.84M | |
| Depreciation and Amortization | NT$ 26.74M | NT$ 28.95M | NT$ 22.57M | NT$ 21.53M | NT$ 9.79M |
| NT$ 245.11M | NT$ 202.84M | NT$ 99.35M | NT$ 103.47M | NT$ 71.31M | |
| NT$ 218.37M | NT$ 170.62M | NT$ 63.63M | NT$ 84.98M | NT$ 61.53M | |
| NT$ 16.42M | NT$ 3.58M | NT$ 12.46M | NT$ -3.74M | NT$ 5.93M | |
| NT$ 234.79M | NT$ 173.43M | NT$ 76.09M | NT$ 81.24M | NT$ 61.55M | |
| NT$ 139.26M | NT$ 113.09M | NT$ 61.99M | NT$ 61.89M | NT$ 47.11M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 3.63 | NT$ 2.94 | NT$ 1.61 | NT$ 1.61 | NT$ 1.23 |
| Diluted EPS | NT$ 3.63 | NT$ 2.94 | NT$ 1.61 | NT$ 1.61 | NT$ 1.23 |
| Weighted Average Shares Outstanding | 51.74M | 38.40M | 38.43M | 38.40M | 38.30M |
| Weighted Average Shares Outstanding (Diluted) | 51.74M | 38.52M | 38.43M | 38.45M | 38.30M |
Currency in TWD
